Israeli medical cannabis company Tikun Olam Cannbit Pharmaceuticals entered the Brazilian market for the first time, the company reported on Wednesday, after signing an agreement with the Brazilian company Ease Labs.
As part of the agreement, Ease Labs will purchase CBD and THC oil and other medical cannabis products in a total volume of a quarter of a ton and will distribute it in the Brazilian market, one of the largest growing markets in South America in the field of medical cannabis.
“This is the first step in the Brazilian market, which is considered one of the largest markets in South America with tremendous growth potential, as part of the realization of the company’s strategic plan and business goals,” said Avinoam Sapir, CEO of Tikun Olam Cannbit.
“We are excited about a fruitful and long-term partnership with Tikun Olam Cannbit” declared Gustavo Valarez, CEO of Ease Labs. “Thanks to the knowledge, experience and quality of the company’s raw materials, together with the local cannabis industry in Brazil, we are confident that the therapeutic products, intended for oncology patients and chronic pain sufferers will facilitate and improve their quality of life and, not least, at affordable prices.”
In 2020, the Israeli company signed an MoU for cooperation with British company ITH Pharma, for the supply of CBD oil and other medical cannabis products in the UK.
According to the agreement, ITH Pharma has undertaken an order to purchase approximately one ton of cannabis oil from the company per year, in bi-monthly doses.
The host of Coffee Mouth Scare Crow Show and CEO of 452 Impact, Inc. Here is food for thought.
Romans 6:23 "For the wages of sin is death; but the gift of God is eternal life through Jesus Christ our Lord."
John 3:16 "For God so love ed the world that he gave his only begotten Son, that whosoever believeth in Him shall be saved."